PPMD 2024 Annual Conference: Day 1 - Navigating the Approved Therapy Landscape

Navigating the Approved Therapy Landscape: Rachel Schrader, MS, APRN, CPNP-PC, PPMD
Newly Approved Therapies - Agamree: Serene Nelson, PharmD, BCCCP, BCMAS, Catalyst Pharmaceuticals
Newly Approved Therapies - Duvyzat: Scott Baver, PhD, ITF Therapeutics
Newly Approved Therapies - Elevidys Expanded Label: Craig McDonald, MD, UC Davis

Current Approved Therapies Panel Discussion

Rachel Schrader, MS, APRN, CPNP-PC, PPMD (Moderator)
Aravindhan Veerapandiayn, MD, Arkansas Children's Hospital
Paula Clemens, MD, University of Pittsburgh
Omer Abdul Hamid, MD, Nemours Children's Hospital
Crystal Proud, MD, Children’s Hospital of the King’s Daughters
Diana Bharucha-Goebel, MD, PhD, Children's National Hospital